Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
American Savings Bank $405 million acquisition by an investor group
We advised American Savings Bank on the transactions
Aptiv corporate reorganization
We advised Aptiv on the corporate reorganization
PineBridge Investments $1.2 billion acquisition by MetLife
We are advising PineBridge on the transaction